Arbutin vs Kojic Acid vs Ethyl Ascorbyl Ether: Korean Whitening Actives for US Indie Brands Under MoCRA (2026)
Alpha-arbutin, kojic acid dipalmitate, ethyl ascorbyl ether: three MFDS whitening actives compared for US indie brands under MoCRA (2026).
Adenosine in Korean ODM Skincare: The MFDS-Listed Anti-Aging Active (2026)
Adenosine is on Korea MFDS wrinkle-improvement functional list. How Korean ODMs formulate it, what the literature supports, and MoCRA claims reality for US indie founders.
Ceramides in Korean ODM Skincare: What the Research Actually Shows (2026)
A research-grounded look at ceramides in Korean ODM skincare: what the peer-reviewed literature actually supports for barrier repair and hydration, and how indie founders should think about formulation and claims in 2026.
K-Beauty Q4 2026 Trends: 5 Formulation Bets Indie Founders Are Placing
5 Q4 2026 K-beauty formulation signals for US indie founders: bakuchiol, barrier stacks, hybrid textures, skinification, SPF flagships. What Korean ODM briefs actually look like.
Cosmetics Manufacturing Plant Cost by Product Type (Korea 2026)
Korean ODM plant cost bands by product type — serum, sunscreen, sheet mask, color cosmetics — with 2026 MOQ math indie founders actually use.
PDRN in Korean ODM Skincare: Sourcing, FDA, Cost (2026)
PDRN topical Korean skincare in 2026: indie founder guide to sourcing, concentration, FDA / MFDS regulatory reality, per-unit cost at 1k-10k MOQ, and the brief mistakes that lose money.